Zentalis Pharmaceuticals, Inc. Common Stock
ZNTL US98943L1070
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 59% | -75% | -27% | -81% | 8% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Myers Scott Dunseth |
1.40 USD |
21,000 Bought |
29,373 USD |
30/04/2025 | 30/04/2025 |
| Bruns Ingmar CMO |
2.28 USD |
20,000 Bought |
45,656 USD |
06/02/2025 | 06/02/2025 |
| Lackner Mark CSO |
1.71 USD |
14,368 Sold |
24,591 USD |
03/02/2025 | 03/02/2025 |
| Vultaggio Vincent SR OFF |
1.71 USD |
2,615 Sold |
4,476 USD |
03/02/2025 | 03/02/2025 |
| Paul Andrea CLO |
1.71 USD |
13,230 Sold |
22,643 USD |
03/02/2025 | 03/02/2025 |
| Skvarka Jan |
1.72 USD |
60,000 Bought |
103,446 USD |
31/01/2025 | 31/01/2025 |
| Eastland Julia Marie CEO |
1.73 USD |
28,500 Bought |
49,345 USD |
31/01/2025 | 31/01/2025 |
| Walker Luke Nathaniel |
1.76 USD |
14,200 Bought |
24,966 USD |
31/01/2025 | 31/01/2025 |
| Lackner Mark CSO |
3.12 USD |
4,411 Sold |
13,762 USD |
02/01/2025 | 02/01/2025 |
| Vultaggio Vincent CCO |
3.18 USD |
1,603 Sold |
5,098 USD |
04/10/2024 | 04/10/2024 |